A detailed history of Nan Fung Group Holdings LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 10,815 shares of BMRN stock, worth $763,322. This represents 1.04% of its overall portfolio holdings.

Number of Shares
10,815
Previous 10,815 -0.0%
Holding current value
$763,322
Previous $944,000 5.72%
% of portfolio
1.04%
Previous 0.93%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$83.81 - $99.0 $603,432 - $712,800
7,200 Added 199.17%
10,815 $944,000
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $312,048 - $361,080
-3,600 Reduced 49.9%
3,615 $313,000
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $96,514 - $128,997
1,100 Added 17.99%
7,215 $701,000
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $99,906 - $124,668
-1,345 Reduced 18.03%
6,115 $471,000
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $535,031 - $682,366
7,460 New
7,460 $659,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.